Yazar "Mayer, Jiri" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.(Lippincott Williams & Wilkins, 2023) Zinzani, Pier Luigi; Mayer, Jiri; Benjamini, Ohad; Berkovits, Alejandro; Glimelius, Ingrid; Stevens, Don A.; Chaudhry, Arvind[Abstract Not Available]Öğe Zilovertamab Vedotin Alone or in Combination With Nemtabrutinib in Aggressive and Indolent B-Cell Malignancies: Phase 2waveLINE-006Study(Wiley, 2023) Zinzani, Pier Luigi; Mayer, Jiri; Benjamini, Ohad; Berkovits, Alejandro; Glimelius, Ingrid; Stevens, Don; Chaudhry, Arvind[Abstract Not Available]
